Premium
Patient participation in medication reviews is desirable but not evidence‐based: a systematic literature review
Author(s) -
Willeboordse Floor,
Hugtenburg Jacqueline G.,
Schellevis François G.,
Elders Petra J. M.
Publication year - 2014
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.12398
Subject(s) - systematic review , patient participation , medicine , identification (biology) , medline , patient satisfaction , evidence based medicine , alternative medicine , family medicine , nursing , botany , political science , law , biology , pathology
Aim The aim of this systematic literature review is to investigate which types of patient participation in medication reviews have been practiced and what is known about the effects of patient participation within the medication review process. Methods A systematic literature review was performed in multiple databases using an extensive selection and quality assessment procedure. Results In total, 37 articles were included and most were assessed with a weak or moderate quality. In all studies patient participation in medication reviews was limited to the level of information giving by the patient to the professional, mainly on actual drug use. Nine studies showed limited results of effects of patient participation on the identification of drug related problems. Conclusions The effects of patient participation are not frequently studied and poorly described in current literature. Nevertheless, involving patients can improve patients' knowledge, satisfaction and the identification of drug related problems. Patient involvement is now limited to information sharing. The profit of higher levels of patient communication and shared decision making is until now, not supported by evidence of its effectiveness.